Walder Wyss Advises Distalmotion on USD 150 Million Series G Financing Round

"Walder Wyss advised Lausanne-based MedTech company Distalmotion on the closing of a USD 150 million Series G financing round led by Revival Healthcare Capital with participation from an existing investor. Proceeds will primarily accelerate US commercial adoption of Dexter and support clinical and product development."

Walder Wyss advised Distalmotion, a globally active MedTech company based in Lausanne, in connection with the closing of its USD 150 million Series G financing round, which was led by Revival Healthcare Capital with participation from an existing investor. The financing round raised USD 150 million. The new funding will be mainly directed at accelerating US commercial adoption of Dexter, Distalmotion’s soft tissue robotic surgery system, and at supporting ongoing clinical and product development initiatives. Walder Wyss represented Distalmotion with a team composed by: partner Alex Nikitine (Corporate and M&A); managing associate Dimitrios Berger (Corporate and M&A); counsel Iliana Djagova (Corporate and M&A); associate Merens Derungs (Corporate and M&A); managing associate Timon Nydegger (Corporate and M&A); senior associate Ken Savioz (Corporate and M&A); senior associate Simon Olstein (Corporate and M&A); and trainee lawyers Lia Müller and Dominik Lusti. Partner André Kuhn advised on notary matters.

Walder Wyss Advises Distalmotion on USD 150 Million Series G Financing Round

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads